Coming months mean IMU will likely do a data cut for Azer-Cel so they know it will be available sometime in the next few months, I suspect they will be released along with the clinical trial update for OASIS. I actually thought they will just wait until end of this year to release the final result for Ph1b clinical trial with this data used to apply for registrational clinical trial. Resolution 2 seem to be a strategy to reset the stock as a biotech start-up IPO and offer the initial "investment" to "Instos" and SI so they can flip the share for a few bagger return on positive clinical trial updates but this are actually further positive clinical trial updates, will the market finally placed true valuation???? Unfortunately, that's how the stock market work with the big boys getting the advantage.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)